Jakob Meier-Credo

Jakob Meier-Credo

Auto-generated profile, based on publicly available information

Jakob Meier-Credo

Max Planck Institute of Biophysics, Frankfurt, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Nature Plants
Verified
Journal Article
Closed access
PDF file
JZJure Zabret
Jure Zabret
SBStefan Bohn
Stefan Bohn
SSSandra K. Schuller
Sandra K. Schuller
OAOliver Arnolds
Oliver Arnolds
MMMadeline Möller
Madeline Möller
MNMarc Nowaczyk
Marc Nowaczyk

4 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LSLinda Schulte
Linda Schulte
JMJiafei Mao
Jiafei Mao
JRJulian Reitz
Julian Reitz
SSSridhar Sreeramulu
Sridhar Sreeramulu
DKDenis Kudlinzki
Denis Kudlinzki
HSHarald Schwalbe
Harald Schwalbe
Understanding the conformational sampling of translation-arrested ribosome nascent chain complexes is key to understand co-translational folding. Up to now, coupling of cysteine oxidation, disulfide bond formation and structure formation in nascent chains has remained elusive. Here, we investigate the eye-lens protein γB-crystallin in the ribosomal exit tunnel. Using mass spectrometry, theoretical simulations, dynamic nuclear polarization-enhanced solid-state nuclear magnetic resonance and cryo-electron microscopy, we show that thiol groups of cysteine residues undergo S-glutathionylation and S-nitrosylation and form non-native disulfide bonds. Thus, covalent modification chemistry occurs already prior to nascent chain release as the ribosome exit tunnel provides sufficient space even for disulfide bond formation which can guide protein folding.

23 November 2022 in Science Advances
Verified
Journal Article
Open access
ELEike Laube
Eike Laube
JMJakob Meier-Credo
Jakob Meier-Credo
JLJulian D. Langer
Julian D. Langer
WKWerner Kühlbrandt
Werner Kühlbrandt
Mitochondrial complex I is a redox-driven proton pump that generates proton-motive force across the inner mitochondrial membrane, powering oxidative phosphorylation and ATP synthesis in eukaryotes. We report the structure of complex I from the thermophilic fungus Chaetomium thermophilum , determined by cryoEM up to 2.4-Å resolution. We show that the complex undergoes a transition between two conformations, which we refer to as state 1 and state 2. The conformational switch is manifest in a twisting movement of the peripheral arm relative to the membrane arm, but most notably in substantial rearrangements of the Q-binding cavity and the E-channel, resulting in a continuous aqueous passage from the E-channel to subunit ND5 at the far end of the membrane arm. The conformational changes in the complex interior resemble those reported for mammalian complex I, suggesting a highly conserved, universal mechanism of coupling electron transport to proton pumping.

13 February 2023 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
LSLasse Sprankel
Lasse Sprankel
DVDavid Vizarraga
David Vizarraga
JMJesús Martín
Jesús Martín
SMSina Manger
Sina Manger
JMJakob Meier-Credo
Jakob Meier-Credo
AFAchilleas S. Frangakis
Achilleas S. Frangakis
Mycoplasma pneumoniae, responsible for approximately 30% of community-acquired human pneumonia, needs to extract lipids from the host environment for survival and proliferation. Here, we report a comprehensive structural and functional analysis of the previously uncharacterized protein P116 (MPN_213). Single-particle cryo-electron microscopy of P116 reveals a homodimer presenting a previously unseen fold, forming a huge hydrophobic cavity, which is fully accessible to solvent. Lipidomics analysis shows that P116 specifically extracts lipids such as phosphatidylcholine, sphingomyelin and cholesterol. Structures of different conformational states reveal the mechanism by which lipids are extracted. This finding immediately suggests a way to control Mycoplasma infection by interfering with lipid uptake.

27 June 2022 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Open access
JMJakob Meier-Credo
Jakob Meier-Credo
LPLaura Preiss
Laura Preiss
IWImke Wüllenweber
Imke Wüllenweber
ARAnja Resemann
Anja Resemann
CNChristoph Nordmann
Christoph Nordmann
JLJulian D. Langer
Julian D. Langer
Identification and sequence determination by mass spectrometry have become routine analyses for soluble proteins. Membrane proteins, however, remain challenging targets due to their hydrophobicity and poor annotation. In particular small membrane proteins often remain unnoticed as they are largely inaccessible to Bottom-Up proteomics. Recent advances in structural biology, though, have led to multiple membrane protein complex structures being determined at sufficiently high resolution to detect uncharacterized, small subunits. In this work we offer a guide for the mass spectrometric characterization of solvent extraction-based purifications of small membrane proteins isolated from protein complexes and cellular membranes. We first demonstrate our Top-Down MALDI-MS/MS approach on a Photosystem II preparation, analyzing target protein masses between 2.5 and 9 kDa with high accuracy and sensitivity. Then we apply our technique to purify and sequence the mycobacterial ATP synthase c subunit, the molecular target of the antibiotic drug bedaquiline. We show that our approach can be used to directly track and pinpoint single amino acid mutations that lead to antibiotic resistance in only 4 h. While not applicable as a high-throughput pipeline, our MALDI-MS/MS and ISD-based approach can identify and provide valuable sequence information on small membrane proteins, which are inaccessible to conventional Bottom-Up techniques. We show that our approach can be used to unambiguously identify single-point mutations leading to antibiotic resistance in mycobacteria.

3 August 2023 in Analytical Chemistry
Verified
Journal Article
Open access
JMJakob Meier-Credo
Jakob Meier-Credo
BHBenjamin Heiniger
Benjamin Heiniger
CSChristian Schori
Christian Schori
FRFiona Rupprecht
Fiona Rupprecht
HMHartmut Michel
Hartmut Michel
JLJulian D. Langer
Julian D. Langer
Small proteins of around 50 aa in length have been largely overlooked in genetic and biochemical assays due to the inherent challenges with detecting and characterizing them. Recent discoveries of their critical roles in many biological processes have led to an increased recognition of the importance of small proteins for basic research and as potential new drug targets. One example is CcoM, a 36 aa subunit of the cbb3-type oxidase that plays an essential role in adaptation to oxygen-limited conditions in Pseudomonas stutzeri (P. stutzeri), a model for the clinically relevant, opportunistic pathogen Pseudomonas aeruginosa. However, as no comprehensive data were available in P. stutzeri, we devised an integrated, generic approach to study small proteins more systematically. Using the first complete genome as basis, we conducted bottom-up proteomics analyses and established a digest-free, direct-sequencing proteomics approach to study cells grown under aerobic and oxygen-limiting conditions. Finally, we also applied a proteogenomics pipeline to identify missed protein-coding genes. Overall, we identified 2921 known and 29 novel proteins, many of which were differentially regulated. Among 176 small proteins 16 were novel. Direct sequencing, featuring a specialized precursor acquisition scheme, exhibited advantages in the detection of small proteins with higher (up to 100%) sequence coverage and more spectral counts, including sequences with high proline content. Three novel small proteins, uniquely identified by direct sequencing and not conserved beyond P. stutzeri, were predicted to form an operon with a conserved protein and may represent de novo genes. These data demonstrate the power of this combined approach to study small proteins in P. stutzeri and show its potential for other prokaryotes.